Number of the records: 1
Optimization of norbornyl-based carbocyclic nucleoside analogs as cyclin-dependent kinase 2 inhibitors
- 1.Köprülüoglu, C., Dejmek, M., Šála, M., Ajani, H., Hřebabecký, H., Fanfrlík, J., Jorda, R., Dračínský, M., Procházková, E., Šácha, P., Kryštof, V., Hobza, P., Lepšík, M., Nencka, R. Optimization of norbornyl-based carbocyclic nucleoside analogs as cyclin-dependent kinase 2 inhibitors. Journal of Molecular Recognition. 2020, 33(8), e2842. ISSN 0952-3499. E-ISSN 1099-1352. Available: doi: 10.1002/jmr.2842.
Number of the records: 1